Targeting the tumor microenvironment: focus on angiogenesis.
about
The immunological effect of hyaluronan in tumor angiogenesisAnti-vascular endothelial growth factor therapy in breast cancerThe tumor microenvironment shapes hallmarks of mature B-cell malignancies.Creation of an apoptin-derived peptide that interacts with SH3 domains and inhibits glioma cell migration and invasion.Predictive model of thrombospondin-1 and vascular endothelial growth factor in breast tumor tissueTargeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity.Enhancement of electroporation facilitated immunogene therapy via T-reg depletion.Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma.A novel 99mTc-labeled molecular probe for tumor angiogenesis imaging in hepatoma xenografts model: a pilot studyCross-talk between endothelial and tumor cells via basic fibroblast growth factor and vascular endothelial growth factor signaling promotes lung cancer growth and angiogenesis.Microvesicles secreted from human multiple myeloma cells promote angiogenesis.E2-EPF UCP regulates stability and functions of missense mutant pVHL via ubiquitin mediated proteolysis.Adverse prognostic impact of bone marrow microvessel density in multiple myelomaInhibition of the angiopoietin/Tie2 axis induces immunogenic modulation, which sensitizes human tumor cells to immune attack.Bispecific targeting of EGFR and uPAR in a mouse model of head and neck squamous cell carcinoma.LY2228820 dimesylate, a selective inhibitor of p38 mitogen-activated protein kinase, reduces angiogenic endothelial cord formation in vitro and in vivo.Postoperative simple biochemical markers for prediction of bone metastases in Egyptian breast cancer patients.Lunasin Attenuates Obesity-Associated Metastasis of 4T1 Breast Cancer Cell through Anti-Inflammatory Property.FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis.A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications.Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.Recruitment and retention: factors that affect pericyte migration.Immunological dysregulation in multiple myeloma microenvironment.Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?Probing the role of mesenchymal stem cells in salivary gland cancer on biomimetic microdevices.Combination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinoma.Potent in vitro and in vivo activity of sorafenib in multiple myeloma: induction of cell death, CD138-downregulation and inhibition of migration through actin depolymerization.Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.Cancer Associated Fibroblasts: The Architects of Stroma Remodeling.Effects of ketoconazole or rifampin on the pharmacokinetics of tivozanib hydrochloride, a vascular endothelial growth factor receptor tyrosine kinase inhibitor.VEGFR-2 expression in malignant tumours of the canine mammary gland: a prospective survival study.Perfusion heterogeneity in breast tumors for assessment of angiogenesis.Association between enhancement patterns and parameters of contrast-enhanced ultrasound and microvessel distribution in breast cancer.
P2860
Q26771483-8539CB40-08E3-4C83-A468-E22C6C47BB80Q26999473-22715910-1D1F-435F-BE20-171521BE9570Q27687567-19F0F80F-E70D-44D7-B0FB-E9A2A4979801Q30008857-959DB9E9-24E9-4C11-8523-F476DF7D3A88Q33897971-DB17A62A-F1DF-47BD-ACDC-4A24B45A2173Q33917555-0BEE2834-9974-45A0-ABBA-E08A8E3490F9Q34072036-FF510E05-8EBB-4E15-9A6C-77E59DBBE97FQ34077263-C124F897-BDAD-41EC-B498-0A35D71FC1ECQ34662173-1CD22525-7A35-4BEC-A083-91FE368D7D5EQ35042233-57434BA7-7588-407F-A790-D243F88F3516Q35077269-204D1415-F06C-4B7F-86BF-98E81B33D448Q35821979-AC08B4D3-1F7B-4D67-A246-04DF09052C36Q36083670-703C0D3A-8808-4594-9015-E5D99C37347EQ36286833-D6949462-3D49-420E-9359-B79C2D82D5E2Q36346628-99E850BB-6B8D-4B43-9A2B-E41F16B59FF8Q36647424-1FE9600B-DE94-4190-AC24-3F944F4B2EAEQ36807447-368058C5-4AF3-417D-98F5-83BCECC5BB96Q37534859-FE285146-53A6-4516-8ADD-6D4816939A8DQ37565073-14A0CE2E-883D-4FED-B53C-A5B8ACE76EC9Q37709866-EFC3221D-1112-4EFE-9A95-1124DE5AF58BQ38090691-7C2B9E5A-0EB0-4FEF-9201-823BB3E2B63AQ38126398-1E1A429D-30D3-4969-881C-F95A29748461Q38228353-12C9798A-2EC7-436A-B575-38AE01A17B10Q38737970-687DCF37-9676-4DB0-8A5E-004CEB13BF87Q38763633-BB766715-0413-4CCB-8D70-13E6E5D08D34Q39365067-9B355FB4-C677-4A15-9C34-DB09BD6E287EQ42969284-2FA047C8-5638-467D-99D0-1DED7E5818AEQ43753506-9768F5A6-2D28-4661-9564-F590425F8903Q47426456-BD5A0F8F-F8A6-4386-98CA-77913A7217FBQ49561501-3950899E-C461-4597-9EA3-F9E1C2EF618EQ53111652-F43338EC-162C-4FC0-BF3E-DC61056C9D51Q54341383-660D7995-A56A-4CAA-B05D-60089A871CE1Q54423416-04F93346-8210-454A-AF0A-04101B0B4D06Q55383572-920D2012-D854-4614-8671-750BC7C2223B
P2860
Targeting the tumor microenvironment: focus on angiogenesis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeting the tumor microenvironment: focus on angiogenesis.
@ast
Targeting the tumor microenvironment: focus on angiogenesis.
@en
type
label
Targeting the tumor microenvironment: focus on angiogenesis.
@ast
Targeting the tumor microenvironment: focus on angiogenesis.
@en
prefLabel
Targeting the tumor microenvironment: focus on angiogenesis.
@ast
Targeting the tumor microenvironment: focus on angiogenesis.
@en
P2093
P2860
P356
P1433
P1476
Targeting the tumor microenvironment: focus on angiogenesis.
@en
P2093
Alexander Schimming
Dirk Jaeger
Fengjuan Fan
Klaus Podar
P2860
P304
P356
10.1155/2012/281261
P577
2011-08-24T00:00:00Z